A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)

NCT04712669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: rodatristat ethyl 300 mg tablet BID
DRUG: rodatristat ethyl 600 mg BID
DRUG: Placebo

Sponsor

Altavant Sciences GmbH